CID 661491

476482-20-9

Structural Information

Molecular Formula
C22H25N7O3S2
SMILES
CN1C2=C(C(=O)N(C1=O)C)N(C(=N2)N3CCC(CC3)C(=O)N)CCSC4=NC5=CC=CC=C5S4
InChI
InChI=1S/C22H25N7O3S2/c1-26-18-16(19(31)27(2)22(26)32)29(20(25-18)28-9-7-13(8-10-28)17(23)30)11-12-33-21-24-14-5-3-4-6-15(14)34-21/h3-6,13H,7-12H2,1-2H3,(H2,23,30)
InChIKey
JFHAOORXBRTLLP-UHFFFAOYSA-N
Compound name
1-[7-[2-(1,3-benzothiazol-2-ylsulfanyl)ethyl]-1,3-dimethyl-2,6-dioxopurin-8-yl]piperidine-4-carboxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

6
References

0
Patents

499.14603 Da
Monoisotopic Mass

2.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 500.15331 215.0
[M+Na]+ 522.13525 227.6
[M-H]- 498.13875 220.7
[M+NH4]+ 517.17985 221.1
[M+K]+ 538.10919 219.2
[M+H-H2O]+ 482.14329 208.2
[M+HCOO]- 544.14423 221.0
[M+CH3COO]- 558.15988 222.5
[M+Na-2H]- 520.12070 210.9
[M]+ 499.14548 222.2
[M]- 499.14658 222.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.